{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Nigella sativa", "antidiabetic", "curcumin", "diabetes mellitus", "hypoglycemic", "insulin signal pathway"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34833928", "DateCompleted": {"Year": "2021", "Month": "12", "Day": "07"}, "DateRevised": {"Year": "2024", "Month": "04", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "11", "Day": "12"}], "Language": ["eng"], "ELocationID": ["6836", "10.3390/molecules26226836"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "22", "PubDate": {"Year": "2021", "Month": "Nov", "Day": "12"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Therapeutic Screening of Herbal Remedies for the Management of Diabetes.", "Abstract": {"AbstractText": ["The study of diabetes mellitus (DM) patterns illustrates increasingly important facts. Most importantly, they include oxidative stress, inflammation, and cellular death. Up to now, there is a shortage of drug therapies for DM, and the discovery and the development of novel therapeutics for this disease are crucial. Medicinal plants are being used more and more as an alternative and natural cure for the disease. Consequently, the objective of this review was to examine the latest results on the effectiveness and protection of natural plants in the management of DM as adjuvant drugs for diabetes and its complex concomitant diseases."]}, "AuthorList": [{"Identifier": ["0000-0002-0876-6604"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria 21511, Egypt."}], "LastName": "Balbaa", "ForeName": "Mahmoud", "Initials": "M"}, {"Identifier": ["0000-0002-2884-8148"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Biochemistry Department, Faculty of Veterinary Medicine, New Valley University, New Valley 72511, Egypt."}], "LastName": "El-Zeftawy", "ForeName": "Marwa", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Science, Alexandria University, Alexandria 21511, Egypt."}, {"Identifier": [], "Affiliation": "Center of Excellency for Preclinical Study (CE-PCS), Pharmaceutical and Fermentation Industries Development Centre, The City of Scientific Research and Technological Applications, Alexandria 21511, Egypt."}], "LastName": "Abdulmalek", "ForeName": "Shaymaa A", "Initials": "SA"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Diabetes Mellitus"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Insulin"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Nouraei H., Jahromi M.G., Jahromi L.R., Zomorodian K., Pakshir K. Potential Pathogenicity of Candida Species Isolated from Oral Cavity of Patients with Diabetes Mellitus. Biomed. Res. Int. 2021;2021:9982744. doi: 10.1155/2021/9982744.", "ArticleIdList": ["10.1155/2021/9982744", "PMC8175137", "34136578"]}, {"Citation": "Abdelalim E.M. Modeling different types of diabetes using human pluripotent stem cells. Cell Mol. Life Sci. 2021;78:2459\u20132483. doi: 10.1007/s00018-020-03710-9.", "ArticleIdList": ["10.1007/s00018-020-03710-9", "33242105"]}, {"Citation": "Altamura S., Mudder K., Schlotterer A., Fleming T., Heidenreich E., Qiu R., Hammes H.P., Nawroth P., Muckenthaler M.U. Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload. Mol. Metab. 2021;51:101235. doi: 10.1016/j.molmet.2021.101235.", "ArticleIdList": ["10.1016/j.molmet.2021.101235", "PMC8131719", "33872860"]}, {"Citation": "Aalaa M., Sanjari M., Esfahani E.N., Atlasi R., Larijani B., Mohajeri-Tehrani M.R., Mehrdad N., Amini M.R. Diabetic Foot scientific activities in Endocrinology and Metabolism Research Institute. J. Diabetes Metab. Disord. 2021:1\u20136. doi: 10.1007/s40200-021-00823-1.", "ArticleIdList": ["10.1007/s40200-021-00823-1", "PMC8630246", "34900823"]}, {"Citation": "Wang H., Zhu Z., Wu J., Wang H., Gao L., Xiao J. Effect of type II diabetes-induced osteoarthritis on articular cartilage aging in rats: A study in vivo and in vitro. Exp. Gerontol. 2021;150:111354. doi: 10.1016/j.exger.2021.111354.", "ArticleIdList": ["10.1016/j.exger.2021.111354", "33872738"]}, {"Citation": "Srivastava B., Sen S., Bhakta S., Sen K. Effect of caffeine on the possible amelioration of diabetic neuropathy: A spectroscopic study. Spectrochim. Acta A Mol. Biomol. Spectrosc. 2021;264:120322. doi: 10.1016/j.saa.2021.120322.", "ArticleIdList": ["10.1016/j.saa.2021.120322", "34509062"]}, {"Citation": "Pal R., Banerjee M. Are people with uncontrolled diabetes mellitus at high risk of reinfections with COVID-19? Prim. Care Diabetes. 2021;15:18\u201320. doi: 10.1016/j.pcd.2020.08.002.", "ArticleIdList": ["10.1016/j.pcd.2020.08.002", "PMC7413202", "32800450"]}, {"Citation": "Ahmed B., Sultana R., Greene M.W. Adipose tissue and insulin resistance in obese. Biomed. Pharm. 2021;137:111315. doi: 10.1016/j.biopha.2021.111315.", "ArticleIdList": ["10.1016/j.biopha.2021.111315", "33561645"]}, {"Citation": "Yang Y., Zhao C., Ye Y., Yu M., Qu X. Prospect of Sodium-Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes. Front. Endocrinol. 2020;11:190. doi: 10.3389/fendo.2020.00190.", "ArticleIdList": ["10.3389/fendo.2020.00190", "PMC7174744", "32351447"]}, {"Citation": "Odawara M., Aoi S., Takeshima T., Iwasaki K. Comparative Effects of Metformin and Dipeptidyl Peptidase-4 Inhibitors in Japanese Obese Patients with Type 2 Diabetes: A Claims Database Study. Diabetes. 2021;12:2165\u20132177. doi: 10.1007/s13300-021-01101-2.", "ArticleIdList": ["10.1007/s13300-021-01101-2", "PMC8342731", "34218420"]}, {"Citation": "van Gorp A.M., Rolfes L., Harmark L., van der Horst P., Hendriks J., Vorstenbosch S. Insight in the safety profile of antidiabetic agents glucagon-like peptide-1 agonists and dipeptidyl peptidase-4 inhibitors in daily practice from the patient perspective. Pharm. Drug Saf. 2020;29:1588\u20131595.", "ArticleIdList": ["32854158"]}, {"Citation": "Didari E., Sarhangi N., Afshari M., Meybodi H.R.A., Hasanzad M.A. pharmacogenetic pilot study of CYP2C9 common genetic variant and sulfonylureas therapeutic response in type 2 diabetes mellitus patients. J. Diabetes Metab. Disord. 2021:1\u20137. doi: 10.1007/s40200-021-00894-0.", "ArticleIdList": ["10.1007/s40200-021-00894-0", "PMC8630254", "34900803"]}, {"Citation": "Rocha R.F., Rodrigues T., Menegatti A.C.O., Bernardes G.J.L., Terenzi H. The antidiabetic drug lobeglitazone has the potential to inhibit PTP1B activity. Bioorg. Chem. 2020;100:103927\u2013103923. doi: 10.1016/j.bioorg.2020.103927.", "ArticleIdList": ["10.1016/j.bioorg.2020.103927", "32422389"]}, {"Citation": "Kathuria D., Raul A.D., Wanjari P., Bharatam P.V. Biguanides: Species with versatile therapeutic applications. Eur. J. Med. Chem. 2021;219:113378\u2013113417. doi: 10.1016/j.ejmech.2021.113378.", "ArticleIdList": ["10.1016/j.ejmech.2021.113378", "33857729"]}, {"Citation": "Panigrahy S.K., Bhatt R., Kumar A. Targeting type II diabetes with plant terpenes: The new and promising antidiabetic therapeutics. Biologia. 2020;76:241\u2013254. doi: 10.2478/s11756-020-00575-y.", "ArticleIdList": ["10.2478/s11756-020-00575-y"]}, {"Citation": "Mutha R.E., Tatiya A.U., Surana S.J. Flavonoids as natural phenolic compounds and their role in therapeutics: An overview. Futur. J. Pharm. Sci. 2021;7:25\u201338. doi: 10.1186/s43094-020-00161-8.", "ArticleIdList": ["10.1186/s43094-020-00161-8", "PMC7816146", "33495733"]}, {"Citation": "Jubaidi F.F., Zainalabidin S., Taib I.S., Hamid Z.A., Budin S.B. The Potential Role of Flavonoids in Ameliorating Diabetic Cardiomyopathy via Alleviation of Cardiac Oxidative Stress, Inflammation and Apoptosis. Int. J. Mol. Sci. 2021;22:5094. doi: 10.3390/ijms22105094.", "ArticleIdList": ["10.3390/ijms22105094", "PMC8151300", "34065781"]}, {"Citation": "Zhang T., Qiu F., Chen L., Liu R., Chang M., Wang X. Identification and in vitro anti-inflammatory activity of different forms of phenolic compounds in Camellia oleifera oil. Food Chem. 2021;344:128660. doi: 10.1016/j.foodchem.2020.128660.", "ArticleIdList": ["10.1016/j.foodchem.2020.128660", "33229148"]}, {"Citation": "Lodhi S., Kori M.L. Structure\u2014Activity Relationship and Therapeutic Benefits of Flavonoids in the Management of Diabetes and Associated Disorders. Pharm. Chem. J. 2021;54:1106\u20131125. doi: 10.1007/s11094-021-02329-9.", "ArticleIdList": ["10.1007/s11094-021-02329-9"]}, {"Citation": "Martin M.A., Ramos S. Dietary Flavonoids and Insulin Signaling in Diabetes and Obesity. Cells. 2021;10:1474. doi: 10.3390/cells10061474.", "ArticleIdList": ["10.3390/cells10061474", "PMC8231211", "34208379"]}, {"Citation": "Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L., Motala A.A., Ogurtsova K., et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pr. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843.", "ArticleIdList": ["10.1016/j.diabres.2019.107843", "31518657"]}, {"Citation": "Ramirez-Moreno A., Quintanar E.M.A., Garcia Garza R., Hady K., Melendez V.A., Marszalek J.E., Sharara-Nunez I., Delgadillo-Guzman D. All-trans retinoic acid improves pancreatic cell proliferation on induced type 1 diabetic rats. Fundam. Clin. Pharm. 2020;34:345\u2013351. doi: 10.1111/fcp.12523.", "ArticleIdList": ["10.1111/fcp.12523", "31762099"]}, {"Citation": "Grizzanti J., Corrigan R., Servizi S., Casadesus G. Amylin signaling in diabetes and Alzheimer\u2019s disease: Therapy or pathology? J. Neurol. Neuromed. 2019;4:12. doi: 10.29245/2572.942X/2019/1.1212.", "ArticleIdList": ["10.29245/2572.942X/2019/1.1212", "PMC6738967", "31511851"]}, {"Citation": "Ortega M.A., Fraile-Mart\u00ednez O., Naya I., Garc\u00eda-Honduvilla N., \u00c1lvarez-Mon M., Buj\u00e1n J., As\u00fansolo \u00c1., de la Torre B. Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications. Nutrients. 2020;12:2749. doi: 10.3390/nu12092749.", "ArticleIdList": ["10.3390/nu12092749", "PMC7551493", "32917030"]}, {"Citation": "El-Zeftawy M., Ali S.A.M., Salah S., Hafez H.S. The functional nutritional and regulatory activities of calcium supplementation from eggshell for obesity disorders management. J. Food Biochem. 2020;44:e13313. doi: 10.1111/jfbc.13313.", "ArticleIdList": ["10.1111/jfbc.13313", "32497284"]}, {"Citation": "Rorbach-Dolata A., Piwowar A. Neurometabolic Evidence Supporting the Hypothesis of Increased Incidence of Type 3 Diabetes Mellitus in the 21st Century. Biomed. Res. Int. 2019;2019:1435276. doi: 10.1155/2019/1435276.", "ArticleIdList": ["10.1155/2019/1435276", "PMC6679855", "31428627"]}, {"Citation": "Jia J.-J., Zeng X.-S., Song X.-Q., Zhang P.-P., Chen L. Diabetes mellitus and Alzheimer\u2019s disease: The protection of epigallocatechin-3-gallate in streptozotocin injection-induced models. Front. Pharmacol. 2017;8:834. doi: 10.3389/fphar.2017.00834.", "ArticleIdList": ["10.3389/fphar.2017.00834", "PMC5702501", "29209211"]}, {"Citation": "Keller A., Varela V.C., Dangol R., Damm P., Heitmann B.L., H\u00e4ndel M.N. The Role of Vitamin D in the Development of Diabetes Post Gestational Diabetes Mellitus: A Systematic Literature Review. Nutrients. 2020;12:1733. doi: 10.3390/nu12061733.", "ArticleIdList": ["10.3390/nu12061733", "PMC7352830", "32531957"]}, {"Citation": "Wu L., Nahm C.B., Jamieson N.B., Samra J., Clifton-Bligh R., Mittal A., Tsang V. Risk factors for development of diabetes mellitus (Type 3c) after partial pancreatectomy: A systematic review. Clin. Endocrinol. 2020;92:396\u2013406. doi: 10.1111/cen.14168.", "ArticleIdList": ["10.1111/cen.14168", "32017157"]}, {"Citation": "Rickels M.R. Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes. Ann. N. Y. Acad. Sci. 2019;1454:68\u201379. doi: 10.1111/nyas.14214.", "ArticleIdList": ["10.1111/nyas.14214", "PMC6945804", "31389033"]}, {"Citation": "Berbudi A., Rahmadika N., Tjahjadi A.I., Ruslami R. Type 2 Diabetes and its Impact on the Immune System. Curr. Diabetes Rev. 2020;16:442\u2013449. doi: 10.2174/1573399815666191024085838.", "ArticleIdList": ["10.2174/1573399815666191024085838", "PMC7475801", "31657690"]}, {"Citation": "Balaji R., Duraisamy R., Kumar M.P. Complications of diabetes mellitus: A review. Drug Invent. Today. 2019;12:98\u2013103."}, {"Citation": "Jud P., Sourij H. Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review. Diabetes Res. Clin. Pr. 2019;148:54\u201363. doi: 10.1016/j.diabres.2018.11.016.", "ArticleIdList": ["10.1016/j.diabres.2018.11.016", "30500546"]}, {"Citation": "Kang G.G., Francis N., Hill R., Waters D., Blanchard C., Santhakumar A.B. Dietary polyphenols and gene expression in molecular pathways associated with type 2 diabetes mellitus: A Review. Int. J. Mol. Sci. 2020;21:140. doi: 10.3390/ijms21010140.", "ArticleIdList": ["10.3390/ijms21010140", "PMC6981492", "31878222"]}, {"Citation": "Daryabor G., Atashzar M.R., Kabelitz D., Meri S., Kalantar K. The effects of type 2 diabetes mellitus on organ metabolism and the immune system. Front. Immunol. 2020;11:1582. doi: 10.3389/fimmu.2020.01582.", "ArticleIdList": ["10.3389/fimmu.2020.01582", "PMC7387426", "32793223"]}, {"Citation": "Cepas V., Collino M., Mayo J.C., Sainz R.M. Redox Signaling and Advanced Glycation Endproducts (AGEs) in Diet-Related Diseases. Antioxidants. 2020;9:142. doi: 10.3390/antiox9020142.", "ArticleIdList": ["10.3390/antiox9020142", "PMC7070562", "32041293"]}, {"Citation": "Dariya B., Nagaraju G.P. Advanced glycation end products in diabetes, cancer and phytochemical therapy. Drug Discov. Today. 2020;25:1614\u20131623. doi: 10.1016/j.drudis.2020.07.003.", "ArticleIdList": ["10.1016/j.drudis.2020.07.003", "32652310"]}, {"Citation": "Chen Y., Jiao N., Jiang M., Liu L., Zhu Y., Wu H., Chen J., Fu Y., Du Q., Xu H. Loganin alleviates testicular damage and germ cell apoptosis induced by AGEs upon diabetes mellitus by suppressing the RAGE/p38MAPK/NF\u2014\u03baB pathway. J. Cell. Mol. Med. 2020;24:6083\u20136095. doi: 10.1111/jcmm.15198.", "ArticleIdList": ["10.1111/jcmm.15198", "PMC7294151", "32307890"]}, {"Citation": "Tang S.G., Liu X.Y., Ye J.M., Hu T.T., Yang Y.Y., Han T., Tan W. Isosteviol ameliorates diabetic cardiomyopathy in rats by inhibiting ERK and NF-kappaB signaling pathways. J. Endocrinol. 2018;238:47\u201360. doi: 10.1530/JOE-17-0681.", "ArticleIdList": ["10.1530/JOE-17-0681", "29720537"]}, {"Citation": "Sharma D., Gondaliya P., Tiwari V., Kalia K. Kaempferol attenuates diabetic nephropathy by inhibiting RhoA/Rho-kinase mediated inflammatory signalling. Biomed. Pharm. 2019;109:1610\u20131619. doi: 10.1016/j.biopha.2018.10.195.", "ArticleIdList": ["10.1016/j.biopha.2018.10.195", "30551415"]}, {"Citation": "Abo El-Nasr N.M.E., Saleh D.O., Mahmoud S.S., Nofal S.M., Abdelsalam R.M., Safar M.M., El-Abhar H.S. Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways. Eur. J. Pharm. 2020;874:173010. doi: 10.1016/j.ejphar.2020.173010.", "ArticleIdList": ["10.1016/j.ejphar.2020.173010", "32067934"]}, {"Citation": "Joshi T., Singh A.K., Haratipour P., Sah A.N., Pandey A.K., Naseri R., Juyal V., Farzaei M.H. Targeting AMPK signaling pathway by natural products for treatment of diabetes mellitus and its complications. J. Cell Physiol. 2019;234:17212\u201317231. doi: 10.1002/jcp.28528.", "ArticleIdList": ["10.1002/jcp.28528", "30916407"]}, {"Citation": "Chen M., Huang N., Liu J., Huang J., Shi J., Jin F. AMPK: A bridge between diabetes mellitus and Alzheimer\u2019s disease. Behav. Brain Res. 2021;400:113043. doi: 10.1016/j.bbr.2020.113043.", "ArticleIdList": ["10.1016/j.bbr.2020.113043", "33307136"]}, {"Citation": "Szrejder M., Piwkowska A. AMPK signalling: Implications for podocyte biology in diabetic nephropathy. Biol. Cell. 2019;111:109\u2013120. doi: 10.1111/boc.201800077.", "ArticleIdList": ["10.1111/boc.201800077", "30702162"]}, {"Citation": "Shrikanth C.B., Nandini C.D. AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants. Phytomedicine. 2020;73:152808. doi: 10.1016/j.phymed.2018.12.031.", "ArticleIdList": ["10.1016/j.phymed.2018.12.031", "30935723"]}, {"Citation": "Ramadass V., Vaiyapuri T., Tergaonkar V. Small molecule NF-\u03baB pathway inhibitors in clinic. Int. J. Mol. Sci. 2020;21:5164. doi: 10.3390/ijms21145164.", "ArticleIdList": ["10.3390/ijms21145164", "PMC7404026", "32708302"]}, {"Citation": "Wu J., Tao W., Bu D., Zhao Y., Zhang T., Chong D., Xue B., Xing Z., Li C. Egr-1 transcriptionally activates protein phosphatase PTP1B to facilitate hyperinsulinemia-induced insulin resistance in the liver in type 2 diabetes. FEBS Lett. 2019;593:3054\u20133063. doi: 10.1002/1873-3468.13537.", "ArticleIdList": ["10.1002/1873-3468.13537", "31309546"]}, {"Citation": "Sun X., Wang X., Zhao Z., Chen J., Li C., Zhao G. Paeoniflorin inhibited nod-like receptor protein-3 inflammasome and NF-kappaB-mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR2. Drug Dev. Res. 2020;82:404\u2013411. doi: 10.1002/ddr.21763.", "ArticleIdList": ["10.1002/ddr.21763", "33236457"]}, {"Citation": "Oguntibeju O.O. Type 2 diabetes mellitus, oxidative stress and inflammation: Examining the links. Int. J. Physiol. Pathophysiol. Pharmacol. 2019;11:45\u201363.", "ArticleIdList": ["PMC6628012", "31333808"]}, {"Citation": "Landon R., Gueguen V., Petite H., Letourneur D., Pavon-Djavid G., Anagnostou F. Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications. Mar. Drugs. 2020;18:357. doi: 10.3390/md18070357.", "ArticleIdList": ["10.3390/md18070357", "PMC7401277", "32660119"]}, {"Citation": "Szymczak-Pajor I., Drzewoski J., Sliwinska A. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders. Int. J. Mol. Sci. 2020;21:6644. doi: 10.3390/ijms21186644.", "ArticleIdList": ["10.3390/ijms21186644", "PMC7554927", "32932777"]}, {"Citation": "Majid M., Masood A., Kadla S.A., Hameed I., Ganai B.A. Association of Pro12Ala Polymorphism of Peroxisome Proliferator-Activated Receptor gamma 2 (PPARgamma2) Gene with Type 2 Diabetes Mellitus in Ethnic Kashmiri Population. Biochem. Genet. 2017;55:10\u201321. doi: 10.1007/s10528-016-9765-6.", "ArticleIdList": ["10.1007/s10528-016-9765-6", "27567620"]}, {"Citation": "Yang Q., Vijayakumar A., Kahn B.B. Metabolites as regulators of insulin sensitivity and metabolism. Nat. Rev. Mol. Cell Biol. 2018;19:654\u2013672. doi: 10.1038/s41580-018-0044-8.", "ArticleIdList": ["10.1038/s41580-018-0044-8", "PMC6380503", "30104701"]}, {"Citation": "Mahmoud M., Kokozidou M., Auffarth A., Schulze-Tanzil G. The Relationship between Diabetes Mellitus Type II and Intervertebral Disc Degeneration in Diabetic Rodent Models: A Systematic and Comprehensive Review. Cells. 2020;9:2208. doi: 10.3390/cells9102208.", "ArticleIdList": ["10.3390/cells9102208", "PMC7600368", "33003542"]}, {"Citation": "Tang S., Wang X., Deng T., Ge H.-P., Xiao X.-C. Identification of C3 as a therapeutic target for diabetic nephropathy by bioinformatics analysis. Sci. Rep. 2020;10:1\u201312.", "ArticleIdList": ["PMC7417539", "32778679"]}, {"Citation": "Jia G., Whaley-Connell A., Sowers J.R. Diabetic cardiomyopathy: A hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61:21\u201328. doi: 10.1007/s00125-017-4390-4.", "ArticleIdList": ["10.1007/s00125-017-4390-4", "PMC5720913", "28776083"]}, {"Citation": "Grzybowski A., Brona P., Lim G., Ruamviboonsuk P., Tan G.S.W., Abramoff M., Ting D.S.W. Artificial intelligence for diabetic retinopathy screening: A review. Eye. 2019;34:451\u2013460. doi: 10.1038/s41433-019-0566-0.", "ArticleIdList": ["10.1038/s41433-019-0566-0", "PMC7055592", "31488886"]}, {"Citation": "Lauri C., Glaudemans A., Campagna G., Keidar Z., Muchnik Kurash M., Georga S., Arsos G., Noriega-Alvarez E., Argento G., Kwee T.C., et al. Comparison of White Blood Cell Scintigraphy, FDG PET/CT and MRI in Suspected Diabetic Foot Infection: Results of a Large Retrospective Multicenter Study. J. Clin. Med. 2020;9:1645. doi: 10.3390/jcm9061645.", "ArticleIdList": ["10.3390/jcm9061645", "PMC7356770", "32486304"]}, {"Citation": "Nashawi M., Sheikh O., Battisha A., Ghali A., Chilton R. Neural tone and cardio-renal outcomes in patients with type 2 diabetes mellitus: A review of the literature with a focus on SGLT2 inhibitors. Heart Fail. Rev. 2020;2020 26:643\u2013652. doi: 10.1007/s10741-020-10046-w.", "ArticleIdList": ["10.1007/s10741-020-10046-w", "33169337"]}, {"Citation": "S\u00f6zen T., Ba\u015faran N.\u00c7., T\u0131nazl\u0131 M., \u00d6z\u0131\u015f\u0131k L. Musculoskeletal problems in diabetes mellitus. Eur. J. Rheumatol. 2018;5:258. doi: 10.5152/eurjrheum.2018.18044.", "ArticleIdList": ["10.5152/eurjrheum.2018.18044", "PMC6267753", "30388074"]}, {"Citation": "Luca M., Di Mauro M., Di Mauro M., Luca A. Gut Microbiota in Alzheimer\u2019s Disease, Depression, and Type 2 Diabetes Mellitus: The Role of Oxidative Stress. Oxid. Med. Cell Longev. 2019;2019:4730539. doi: 10.1155/2019/4730539.", "ArticleIdList": ["10.1155/2019/4730539", "PMC6501164", "31178961"]}, {"Citation": "Lega I.C., Lipscombe L.L. Review: Diabetes, Obesity, and Cancer-Pathophysiology and Clinical Implications. Endocr. Rev. 2020;41:33\u201352. doi: 10.1210/endrev/bnz014.", "ArticleIdList": ["10.1210/endrev/bnz014", "31722374"]}, {"Citation": "Abo Baker S., Moawad A. Anti-diabetic effect of Moringa oleifera extract on parotid gland of albino rats. Egypt. Dent. J. 2020;66:187\u2013196. doi: 10.21608/edj.2020.77534.", "ArticleIdList": ["10.21608/edj.2020.77534"]}, {"Citation": "Reddy P.K., Kuchay M.S., Mehta Y., Mishra S.K. Diabetic ketoacidosis precipitated by COVID-19: A report of two cases and review of literature. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:1459\u20131462. doi: 10.1016/j.dsx.2020.07.050.", "ArticleIdList": ["10.1016/j.dsx.2020.07.050", "PMC7395228", "32771918"]}, {"Citation": "Raju B., Santhanakumar K.S., Kesavachandran U. Gastrointestinal involvement of unusual Mucormycete Syncephalastrum racemosum in a diabetic patient with adenocarcinoma: Rare case presentation with review of literature. Infection. 2020;48:791\u2013797. doi: 10.1007/s15010-020-01455-y.", "ArticleIdList": ["10.1007/s15010-020-01455-y", "32506307"]}, {"Citation": "Hussain A., Bhowmik B., do Vale Moreira N.C. COVID-19 and diabetes: Knowledge in progress. Diabetes Res. Clin. Pract. 2020;162:108142. doi: 10.1016/j.diabres.2020.108142.", "ArticleIdList": ["10.1016/j.diabres.2020.108142", "PMC7144611", "32278764"]}, {"Citation": "Pal R., Banerjee M., Yadav U., Bhattacharjee S. Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: A systematic review of literature. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;14:1563\u20131569. doi: 10.1016/j.dsx.2020.08.015.", "ArticleIdList": ["10.1016/j.dsx.2020.08.015", "PMC7434433", "32853901"]}, {"Citation": "Lim S., Bae J.H., Kwon H.S., Nauck M.A. COVID-19 and diabetes mellitus: From pathophysiology to clinical management. Nat. Rev. Endocrinol. 2021;17:11\u201330. doi: 10.1038/s41574-020-00435-4.", "ArticleIdList": ["10.1038/s41574-020-00435-4", "PMC7664589", "33188364"]}, {"Citation": "Mohebbati R., Abbasnezhad A. Effects of Nigella sativa on endothelial dysfunction in diabetes mellitus: A review. J. Ethnopharmacol. 2020;252:112585. doi: 10.1016/j.jep.2020.112585.", "ArticleIdList": ["10.1016/j.jep.2020.112585", "31972323"]}, {"Citation": "Lutterodt H., Luther M., Slavin M., Yin J.-J., Parry J., Gao J.-M., Yu L. Fatty acid profile, thymoquinone content, oxidative stability, and antioxidant properties of cold-pressed black cumin seed oils. LWT Food Sci. Technol. 2010;43:1409\u20131413. doi: 10.1016/j.lwt.2010.04.009.", "ArticleIdList": ["10.1016/j.lwt.2010.04.009"]}, {"Citation": "Malaguarnera G., Cataudella E., Giordano M., Nunnari G., Chisari G., Malaguarnera M. Toxic hepatitis in occupational exposure to solvents. World J. Gastroenterol. 2012;18:2756\u20132766. doi: 10.3748/wjg.v18.i22.2756.", "ArticleIdList": ["10.3748/wjg.v18.i22.2756", "PMC3374978", "22719183"]}, {"Citation": "Balbaa M., Abdulmalek S.A., Khalil S. Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugs. PLoS ONE. 2017;12:e0172429. doi: 10.1371/journal.pone.0172429.", "ArticleIdList": ["10.1371/journal.pone.0172429", "PMC5432169", "28505155"]}, {"Citation": "Balbaa M., El-Zeftawy M., Ghareeb D., Taha N., Mandour A.W. Nigella sativa relieves the altered insulin receptor signaling in streptozotocin-induced diabetic rats fed with a high-fat diet. Oxidative Med. Cell. Longev. 2016;2016:1\u201316. doi: 10.1155/2016/2492107.", "ArticleIdList": ["10.1155/2016/2492107", "PMC4989085", "27579151"]}, {"Citation": "Shahin Y.R., Elguindy N.M., Abdel Bary A., Balbaa M. The protective mechanism of Nigella sativa against diethylnitrosamine-induced hepatocellular carcinoma through its antioxidant effect and EGFR/ERK1/2 signaling. Environ. Toxicol. 2018;33:885\u2013898. doi: 10.1002/tox.22574.", "ArticleIdList": ["10.1002/tox.22574", "29923357"]}, {"Citation": "Kaur G., Invally M., Khan M.K., Jadhav P. A nutraceutical combination of Cinnamomum cassia &Nigella sativa for Type 1 diabetes mellitus. J. Ayurveda Integr. Med. 2018;9:27\u201337.", "ArticleIdList": ["PMC5884041", "28988684"]}, {"Citation": "Hamdan A., Haji Idrus R., Mokhtar M.H. Effects of Nigella Sativa on Type-2 Diabetes Mellitus: A Systematic Review. Int. J. Environ. Res. Public Health. 2019;16:4911. doi: 10.3390/ijerph16244911.", "ArticleIdList": ["10.3390/ijerph16244911", "PMC6950756", "31817324"]}, {"Citation": "Alli-oluwafuyi A.-M., Amin A., Abdulmajeed W.I., Imam A., Niyi-odumosu F., Abdulraheem H., Gwadabe S., Biliaminu A.S. Nigella sativa L. oil ameliorates insulin resistance caused by dexamethasone treatment in male Wistar rats. Afr. J. Pharm. Pharmacol. 2017;11:144\u2013151. doi: 10.5897/AJPP2016.4705.", "ArticleIdList": ["10.5897/AJPP2016.4705"]}, {"Citation": "Balbaa M., El-Zeftawy M., Abdulmalek S.A., Shahin Y.R. Black Cumin (Nigella sativa) Seeds: Chemistry, Technology, Functionality, and Applications. Springer; Cham, Switzerland: 2021. Health-Promoting Activities of Nigella sativa Fixed Oil; pp. 361\u2013379."}, {"Citation": "Meddah B., Ducroc R., El Abbes Faouzi M., Eto B., Mahraoui L., Benhaddou-Andaloussi A., Martineau L.C., Cherrah Y., Haddad P.S. Nigella sativa inhibits intestinal glucose absorption and improves glucose tolerance in rats. J. Ethnopharmacol. 2009;121:419\u2013424. doi: 10.1016/j.jep.2008.10.040.", "ArticleIdList": ["10.1016/j.jep.2008.10.040", "19061948"]}, {"Citation": "Sobhi W., Stevigny C., Duez P., Calderon B.B., Atmani D., Benboubetra M. Effect of lipid extracts of Nigella sativa L. seeds on the liver ATP reduction and alpha-glucosidase inhibition. Pak. J. Pharm. Sci. 2016;29:111\u2013117.", "ArticleIdList": ["26826824"]}, {"Citation": "Elseweidy M.M., Amin R.S., Atteia H.H., Aly M.A. Nigella sativa Oil and Chromium Picolinate Ameliorate Fructose-Induced Hyperinsulinemia by Enhancing Insulin Signaling and Suppressing Insulin-Degrading Enzyme in Male Rats. Biol. Trace Elem. Res. 2018;184:119\u2013126. doi: 10.1007/s12011-017-1167-z.", "ArticleIdList": ["10.1007/s12011-017-1167-z", "28975521"]}, {"Citation": "Rashidmayvan M., Mohammadshahi M., Seyedian S.S., Haghighizadeh M.H. The effect of Nigella sativa oil on serum levels of inflammatory markers, liver enzymes, lipid profile, insulin and fasting blood sugar in patients with non-alcoholic fatty liver. J. Diabetes Metab. Disord. 2019;18:453\u2013459. doi: 10.1007/s40200-019-00439-6.", "ArticleIdList": ["10.1007/s40200-019-00439-6", "PMC6915184", "31890671"]}, {"Citation": "Wu J., Jin Z., Zheng H., Yan L.J. Sources and implications of NADH/NAD(+) redox imbalance in diabetes and its complications. Diabetes Metab. Syndr. Obes. 2016;9:145\u2013153.", "ArticleIdList": ["PMC4869616", "27274295"]}, {"Citation": "Karandrea S., Yin H., Liang X., Slitt A.L., Heart E.A. Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways. PLoS ONE. 2017;12:e0185374. doi: 10.1371/journal.pone.0185374.", "ArticleIdList": ["10.1371/journal.pone.0185374", "PMC5614580", "28950020"]}, {"Citation": "Kitada M., Koya D. SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential. Diabetes Metab. J. 2013;37:315\u2013325. doi: 10.4093/dmj.2013.37.5.315.", "ArticleIdList": ["10.4093/dmj.2013.37.5.315", "PMC3816131", "24199159"]}, {"Citation": "Kooshki A., Tofighiyan T., Rastgoo N., Rakhshani M.H., Miri M. Effect of Nigella sativa oil supplement on risk factors for cardiovascular diseases in patients with type 2 diabetes mellitus. Phytother. Res. 2020;34:2706\u20132711. doi: 10.1002/ptr.6707.", "ArticleIdList": ["10.1002/ptr.6707", "32510754"]}, {"Citation": "Mahmoodi M.R., Mohammadizadeh M. Therapeutic potentials of Nigella sativa preparations and its constituents in the management of diabetes and its complications in experimental animals and patients with diabetes mellitus: A systematic review. Complement. Med. 2020;50:102391. doi: 10.1016/j.ctim.2020.102391.", "ArticleIdList": ["10.1016/j.ctim.2020.102391", "32444053"]}, {"Citation": "Xu X., Yi H., Wu J., Kuang T., Zhang J., Li Q., Du H., Xu T., Jiang G., Fan G. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed. Pharm. 2021;133:110984. doi: 10.1016/j.biopha.2020.110984.", "ArticleIdList": ["10.1016/j.biopha.2020.110984", "33186794"]}, {"Citation": "Belwal T., Bisht A., Devkota H.P., Ullah H., Khan H., Pandey A., Bhatt I.D., Echeverria J. Phytopharmacology and Clinical Updates of Berberis Species Against Diabetes and Other Metabolic Diseases. Front. Pharm. 2020;11:41. doi: 10.3389/fphar.2020.00041.", "ArticleIdList": ["10.3389/fphar.2020.00041", "PMC7040237", "32132921"]}, {"Citation": "Liu X., Wang K., Zhou J., Sullivan M.A., Liu Y., Gilbert R.G., Deng B. Metformin and Berberine suppress glycogenolysis by inhibiting glycogen phosphorylase and stabilizing the molecular structure of glycogen in db/db mice. Carbohydr. Polym. 2020;243:116435. doi: 10.1016/j.carbpol.2020.116435.", "ArticleIdList": ["10.1016/j.carbpol.2020.116435", "32532388"]}, {"Citation": "Amin A.R., Kassab R.B., Abdel Moneim A.E., Amin H.K. Comparison among garlic, berberine, resveratrol, Hibiscus sabdariffa, genus Zizyphus, hesperidin, red beetroot, Catha edulis, Portulaca oleracea, and mulberry leaves in the treatment of hypertension and type 2 DM: A comprehensive review. Nat. Prod. Commun. 2020;15:1934578X20921623."}, {"Citation": "Meng Z., Yu Y., Zhang Y., Yang X., Lv X., Guan F., Hatch G.M., Zhang M., Chen L. Highly bioavailable Berberine formulation improves Glucocorticoid Receptor-mediated Insulin Resistance via reduction in association of the Glucocorticoid Receptor with phosphatidylinositol-3-kinase. Int. J. Biol. Sci. 2020;16:2527\u20132541. doi: 10.7150/ijbs.39508.", "ArticleIdList": ["10.7150/ijbs.39508", "PMC7415432", "32792855"]}, {"Citation": "Song D., Hao J., Fan D. Biological properties and clinical applications of berberine. Front. Med. 2020;14:564\u2013582. doi: 10.1007/s11684-019-0724-6.", "ArticleIdList": ["10.1007/s11684-019-0724-6", "32335802"]}, {"Citation": "Wang H., Zhu C., Ying Y., Luo L., Huang D., Luo Z. Metformin and berberine, two versatile drugs in treatment of common metabolic diseases. Oncotarget. 2018;9:10135. doi: 10.18632/oncotarget.20807.", "ArticleIdList": ["10.18632/oncotarget.20807", "PMC5839379", "29515798"]}, {"Citation": "Wu L., Xia M., Duan Y., Zhang L., Jiang H., Hu X., Yan H., Zhang Y., Gu Y., Shi H., et al. Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans. Cell Death Dis. 2019;10:468. doi: 10.1038/s41419-019-1706-y.", "ArticleIdList": ["10.1038/s41419-019-1706-y", "PMC6565685", "31197160"]}, {"Citation": "Ni Y., Xu Z., Li C., Zhu Y., Liu R., Zhang F., Chang H., Li M., Sheng L., Li Z., et al. Therapeutic inhibition of miR-802 protects against obesity through AMPK-mediated regulation of hepatic lipid metabolism. Theranostics. 2021;11:1079\u20131099. doi: 10.7150/thno.49354.", "ArticleIdList": ["10.7150/thno.49354", "PMC7738900", "33391522"]}, {"Citation": "El-Zeftawy M., Ghareeb D., ElBealy E.R., Saad R., Mahmoud S., Elguindy N., El-Kott A.F., El-Sayed M. Berberine chloride ameliorated PI3K/Akt-p/SIRT-1/PTEN signaling pathway in insulin resistance syndrome induced in rats. J. Food Biochem. 2019;43:e13049. doi: 10.1111/jfbc.13049.", "ArticleIdList": ["10.1111/jfbc.13049", "31512260"]}, {"Citation": "Li M., Zhou W., Dang Y., Li C., Ji G., Zhang L. Berberine compounds improve hyperglycemia via microbiome mediated colonic TGR5-GLP pathway in db/db mice. Biomed. Pharm. 2020;132:110953. doi: 10.1016/j.biopha.2020.110953.", "ArticleIdList": ["10.1016/j.biopha.2020.110953", "33254441"]}, {"Citation": "Cui H.X., Hu Y.N., Li J.W., Yuan K. Hypoglycemic Mechanism of the Berberine Organic Acid Salt under the Synergistic Effect of Intestinal Flora and Oxidative Stress. Oxid. Med. Cell Longev. 2018;2018:8930374. doi: 10.1155/2018/8930374.", "ArticleIdList": ["10.1155/2018/8930374", "PMC6313974", "30662584"]}, {"Citation": "Ilyas Z., Perna S., Al-Thawadi S., Alalwan T.A., Riva A., Petrangolini G., Gasparri C., Infantino V., Peroni G., Rondanelli M. The effect of Berberine on weight loss in order to prevent obesity: A systematic review. Biomed. Pharm. 2020;127:110137. doi: 10.1016/j.biopha.2020.110137.", "ArticleIdList": ["10.1016/j.biopha.2020.110137", "32353823"]}, {"Citation": "Yue S.J., Liu J., Wang A.T., Meng X.T., Yang Z.R., Peng C., Guan H.S., Wang C.Y., Yan D. Berberine alleviates insulin resistance by reducing peripheral branched-chain amino acids. Am. J. Physiol. Endocrinol. Metab. 2019;316:E73\u2013E85. doi: 10.1152/ajpendo.00256.2018.", "ArticleIdList": ["10.1152/ajpendo.00256.2018", "30422704"]}, {"Citation": "Qin X., Jiang M., Zhao Y., Gong J., Su H., Yuan F., Fang K., Yuan X., Yu X., Dong H., et al. Berberine protects against diabetic kidney disease via promoting PGC-1alpha-regulated mitochondrial energy homeostasis. Br. J. Pharm. 2020;177:3646\u20133661. doi: 10.1111/bph.14935.", "ArticleIdList": ["10.1111/bph.14935", "PMC7393204", "31734944"]}, {"Citation": "Liu L.Z., Cheung S.C., Lan L.L., Ho S.K., Xu H.X., Chan J.C., Tong P.C. Berberine modulates insulin signaling transduction in insulin-resistant cells. Mol. Cell Endocrinol. 2010;317:148\u2013153. doi: 10.1016/j.mce.2009.12.027.", "ArticleIdList": ["10.1016/j.mce.2009.12.027", "20036710"]}, {"Citation": "Hu R., Wang M.Q., Ni S.H., Wang M., Liu L.Y., You H.Y., Wu X.H., Wang Y.J., Lu L., Wei L.B. Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-kappaB/NLRP3 signaling pathway in AGEs-induced HUVECs. Eur. J. Pharm. 2020;867:172797. doi: 10.1016/j.ejphar.2019.172797.", "ArticleIdList": ["10.1016/j.ejphar.2019.172797", "31747547"]}, {"Citation": "Calvani M., Subbiani A., Bruno G., Favre C. Beta-Blockers and Berberine: A Possible Dual Approach to Contrast Neuroblastoma Growth and Progression. Oxid. Med. Cell Longev. 2020;2020:7534693. doi: 10.1155/2020/7534693.", "ArticleIdList": ["10.1155/2020/7534693", "PMC7443044", "32855766"]}, {"Citation": "Li C., Ai G., Wang Y., Lu Q., Luo C., Tan L., Lin G., Liu Y., Li Y., Zeng H., et al. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-kappaB pathway. Pharm. Res. 2020;152:104603. doi: 10.1016/j.phrs.2019.104603.", "ArticleIdList": ["10.1016/j.phrs.2019.104603", "31863867"]}, {"Citation": "Ma X., Chen Z., Wang L., Wang G., Wang Z., Dong X., Wen B., Zhang Z. The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation: Its Inhibition by Berberine. Front. Pharm. 2018;9:782. doi: 10.3389/fphar.2018.00782.", "ArticleIdList": ["10.3389/fphar.2018.00782", "PMC6072898", "30100874"]}, {"Citation": "Mahata S., Bharti A.C., Shukla S., Tyagi A., Husain S.A., Das B.C. Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells. Mol. Cancer. 2011;10:39. doi: 10.1186/1476-4598-10-39.", "ArticleIdList": ["10.1186/1476-4598-10-39", "PMC3098825", "21496227"]}, {"Citation": "Ashrafizadeh M., Fekri H.S., Ahmadi Z., Farkhondeh T., Samarghandian S. Therapeutic and biological activities of berberine: The involvement of Nrf2 signaling pathway. J. Cell Biochem. 2020;121:1575\u20131585. doi: 10.1002/jcb.29392.", "ArticleIdList": ["10.1002/jcb.29392", "31609017"]}, {"Citation": "Zych M., Wojnar W., Kielanowska M., Folwarczna J., Kaczmarczyk-Sedlak I. Effect of Berberine on Glycation, Aldose Reductase Activity, and Oxidative Stress in the Lenses of Streptozotocin-Induced Diabetic Rats In Vivo-A Preliminary Study. Int. J. Mol. Sci. 2020;21:4278. doi: 10.3390/ijms21124278.", "ArticleIdList": ["10.3390/ijms21124278", "PMC7349706", "32560082"]}, {"Citation": "Sharifi-Rad J., Rayess Y.E., Rizk A.A., Sadaka C., Zgheib R., Zam W., Sestito S., Rapposelli S., Neffe-Skocinska K., Zielinska D., et al. Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications. Front. Pharm. 2020;11:01021. doi: 10.3389/fphar.2020.01021.", "ArticleIdList": ["10.3389/fphar.2020.01021", "PMC7522354", "33041781"]}, {"Citation": "Balbaa M., El-Zeftawy M., Taha N., Mandour A.W. Zinc and curcumin lower arylsulfatses and some metabolic parameters in streptozotocin-induced diabetes. J. Diabetes Metab. Disord. 2017;16:11. doi: 10.1186/s40200-017-0293-7.", "ArticleIdList": ["10.1186/s40200-017-0293-7", "PMC5348748", "28293546"]}, {"Citation": "Ibanez M.D., Blazquez M.A. Curcuma longa L. Rhizome Essential Oil from Extraction to Its Agri-Food Applications. A Review. Plants. 2020;10:44. doi: 10.3390/plants10010044.", "ArticleIdList": ["10.3390/plants10010044", "PMC7823572", "33379197"]}, {"Citation": "Panahi Y., Ahmadi Y., Teymouri M., Johnston T.P., Sahebkar A. Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic mechanisms. J. Cell Physiol. 2018;233:141\u2013152. doi: 10.1002/jcp.25756.", "ArticleIdList": ["10.1002/jcp.25756", "28012169"]}, {"Citation": "Jin T.R. Curcumin and dietary polyphenol research: Beyond drug discovery. Acta Pharm. Sin. 2018;39:779\u2013786. doi: 10.1038/aps.2017.179.", "ArticleIdList": ["10.1038/aps.2017.179", "PMC5943900", "29542686"]}, {"Citation": "Li J.M., Li Y.C., Kong L.D., Hu Q.H. Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology. 2010;51:1555\u20131566. doi: 10.1002/hep.23524.", "ArticleIdList": ["10.1002/hep.23524", "20222050"]}, {"Citation": "Jimenez-Osorio A.S., Monroy A., Alavez S. Curcumin and insulin resistance-Molecular targets and clinical evidences. Biofactors. 2016;42:561\u2013580. doi: 10.1002/biof.1302.", "ArticleIdList": ["10.1002/biof.1302", "27325504"]}, {"Citation": "Eshaghian A., Khodarahmi A., Safari F., Binesh F., Moradi A. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats. Br. J. Nutr. 2018;120:393\u2013403. doi: 10.1017/S0007114518001095.", "ArticleIdList": ["10.1017/S0007114518001095", "29880071"]}, {"Citation": "Wojcik M., Krawczyk M., Wojcik P., Cypryk K., Wozniak L.A. Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer. Oxid Med. Cell Longev. 2018;2018:9698258. doi: 10.1155/2018/9698258.", "ArticleIdList": ["10.1155/2018/9698258", "PMC5884026", "29743988"]}, {"Citation": "Xia Z.H., Zhang S.Y., Chen Y.S., Li K., Chen W.B., Liu Y.Q. Curcumin anti-diabetic effect mainly correlates with its anti-apoptotic actions and PI3K/Akt signal pathway regulation in the liver. Food Chem. Toxicol. 2020;146:111803. doi: 10.1016/j.fct.2020.111803.", "ArticleIdList": ["10.1016/j.fct.2020.111803", "33035629"]}, {"Citation": "Lee Y.S., Cho D.C., Kim C.H., Han I., Gil E.Y., Kim K.T. Effect of curcumin on the inflammatory reaction and functional recovery after spinal cord injury in a hyperglycemic rat model. Spine J. 2019;19:2025\u20132039. doi: 10.1016/j.spinee.2019.07.013.", "ArticleIdList": ["10.1016/j.spinee.2019.07.013", "31421247"]}, {"Citation": "Thota R.N., Rosato J.I., Dias C.B., Burrows T.L., Martins R.N., Garg M.L. Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3beta and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer\u2019s Disease. Nutrients. 2020;12:1032. doi: 10.3390/nu12041032.", "ArticleIdList": ["10.3390/nu12041032", "PMC7230780", "32283762"]}, {"Citation": "Abdollahi E., Momtazi A.A., Johnston T.P., Sahebkar A. Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades? J. Cell Physiol. 2018;233:830\u2013848. doi: 10.1002/jcp.25778.", "ArticleIdList": ["10.1002/jcp.25778", "28059453"]}, {"Citation": "Kuo J.J., Chang H.H., Tsai T.H., Lee T.Y. Curcumin ameliorates mitochondrial dysfunction associated with inhibition of gluconeogenesis in free fatty acid-mediated hepatic lipoapoptosis. Int. J. Mol. Med. 2012;30:643\u2013649. doi: 10.3892/ijmm.2012.1020.", "ArticleIdList": ["10.3892/ijmm.2012.1020", "22692588"]}, {"Citation": "Simmons E.C., Scholpa N.E., Schnellmann R.G. Mitochondrial biogenesis as a therapeutic target for traumatic and neurodegenerative CNS diseases. Exp. Neurol. 2020;329:113309. doi: 10.1016/j.expneurol.2020.113309.", "ArticleIdList": ["10.1016/j.expneurol.2020.113309", "PMC7735537", "32289315"]}, {"Citation": "Lone J., Choi J.H., Kim S.W., Yun J.W. Curcumin induces brown fat-like phenotype in 3T3-L1 and primary white adipocytes. J. Nutr. Biochem. 2016;27:193\u2013202. doi: 10.1016/j.jnutbio.2015.09.006.", "ArticleIdList": ["10.1016/j.jnutbio.2015.09.006", "26456563"]}, {"Citation": "Moulin S., Arnaud C., Bouyon S., Pepin J.L., Godin-Ribuot D., Belaidi E. Curcumin prevents chronic intermittent hypoxia-induced myocardial injury. Adv. Chronic Dis. 2020;11:2040622320922104. doi: 10.1177/2040622320922104.", "ArticleIdList": ["10.1177/2040622320922104", "PMC7315663", "32637058"]}, {"Citation": "Bahrami A., Atkin S.L., Majeed M., Sahebkar A. Effects of curcumin on hypoxia-inducible factor as a new therapeutic target. Pharm. Res. 2018;137:159\u2013169. doi: 10.1016/j.phrs.2018.10.009.", "ArticleIdList": ["10.1016/j.phrs.2018.10.009", "30315965"]}, {"Citation": "Pu Y., Zhang H., Wang P., Zhao Y., Li Q., Wei X., Cui Y., Sun J., Shang Q., Liu D., et al. Dietary curcumin ameliorates aging-related cerebrovascular dysfunction through the AMPK/uncoupling protein 2 pathway. Cell Physiol. Biochem. 2013;32:1167\u20131177. doi: 10.1159/000354516.", "ArticleIdList": ["10.1159/000354516", "24335167"]}, {"Citation": "Dludla P.V., Nkambule B.B., Tiano L., Louw J., Jastroch M., Mazibuko-Mbeje S.E. Uncoupling proteins as a therapeutic target to protect the diabetic heart. Pharm. Res. 2018;137:11\u201324. doi: 10.1016/j.phrs.2018.09.013.", "ArticleIdList": ["10.1016/j.phrs.2018.09.013", "30223086"]}, {"Citation": "Su J., Zhou X., Wang L., Yin X., Wang Z. Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells. Am. J. Cancer Res. 2016;6:1949\u20131962.", "ArticleIdList": ["PMC5043105", "27725901"]}, {"Citation": "Tsai Y.C., Kuo P.L., Kuo M.C., Hung W.W., Wu L.Y., Chang W.A., Wu P.H., Lee S.C., Chen H.C., Hsu Y.L. The Interaction of miR-378i-Skp2 Regulates Cell Senescence in Diabetic Nephropathy. J. Clin. Med. 2018;7:468. doi: 10.3390/jcm7120468.", "ArticleIdList": ["10.3390/jcm7120468", "PMC6306775", "30469549"]}, {"Citation": "Al-Malki A.L., El Rabey H.A. The antidiabetic effect of low doses of Moringa oleifera Lam. seeds on streptozotocin induced diabetes and diabetic nephropathy in male rats. Biomed. Res. Int. 2015;2015:381040. doi: 10.1155/2015/381040.", "ArticleIdList": ["10.1155/2015/381040", "PMC4299558", "25629046"]}, {"Citation": "Nova E., Redondo-Useros N., Martinez-Garcia R.M., Gomez-Martinez S., Diaz-Prieto L.E., Marcos A. Potential of Moringa oleifera to Improve Glucose Control for the Prevention of Diabetes and Related Metabolic Alterations: A Systematic Review of Animal and Human Studies. Nutrients. 2020;12:2050. doi: 10.3390/nu12072050.", "ArticleIdList": ["10.3390/nu12072050", "PMC7400864", "32664295"]}, {"Citation": "Jaiswal D., Kumar Rai P., Kumar A., Mehta S., Watal G. Effect of Moringa oleifera Lam. leaves aqueous extract therapy on hyperglycemic rats. J. Ethnopharmacol. 2009;123:392\u2013396. doi: 10.1016/j.jep.2009.03.036.", "ArticleIdList": ["10.1016/j.jep.2009.03.036", "19501271"]}, {"Citation": "Tshabalala T., Ndhlala A.R., Ncube B., Abdelgadir H.A., Van Staden J. Potential substitution of the root with the leaf in the use of Moringa oleifera for antimicrobial, antidiabetic and antioxidant properties. South. Afr. J. Bot. 2020;129:106\u2013112. doi: 10.1016/j.sajb.2019.01.029.", "ArticleIdList": ["10.1016/j.sajb.2019.01.029"]}, {"Citation": "Fatoumata B.A., MamadouSa\u00efdou B.A.H., Mohamet S., Joseph K.S., Modou M.G., El Hadji M.B.A. Antidiabetic properties of Moringa oleifera: A review of the literature. J. Diabetes Endocrinol. 2020;11:18\u201329. doi: 10.5897/JDE2019.0136.", "ArticleIdList": ["10.5897/JDE2019.0136"]}, {"Citation": "Ma Z.F., Ahmad J., Zhang H., Khan I., Muhammad S. Evaluation of phytochemical and medicinal properties of Moringa (Moringa oleifera) as a potential functional food. South. Afr. J. Bot. 2020;129:40\u201346. doi: 10.1016/j.sajb.2018.12.002.", "ArticleIdList": ["10.1016/j.sajb.2018.12.002"]}, {"Citation": "Attakpa E.S., Sangar\u00e9 M.M., B\u00e9hanzin G.J., Ategbo J.M., Seri B., Khan N.A. Moringa olifeira Lam. stimulates activation of the insulin-dependent akt pathway. Antidiabetic effect in a diet-induced obesity (DIO) mouse model. Folia Biol. 2017;63:42.", "ArticleIdList": ["28557705"]}, {"Citation": "Bao Y., Xiao J., Weng Z., Lu X., Shen X., Wang F. A phenolic glycoside from Moringa oleifera Lam. improves the carbohydrate and lipid metabolisms through AMPK in db/db mice. Food Chem. 2020;311:125948. doi: 10.1016/j.foodchem.2019.125948.", "ArticleIdList": ["10.1016/j.foodchem.2019.125948", "31877545"]}, {"Citation": "Wang F., Bao Y., Shen X., Zengin G., Lyu Y., Xiao J., Weng Z. Niazirin from Moringa oleifera Lam. attenuates high glucose-induced oxidative stress through PKCzeta/Nox4 pathway. Phytomedicine. 2019:153066. doi: 10.1016/j.phymed.2019.153066.", "ArticleIdList": ["10.1016/j.phymed.2019.153066", "31447278"]}, {"Citation": "Chen G.L., Xu Y.B., Wu J.L., Li N., Guo M.Q. Hypoglycemic and hypolipidemic effects of Moringa oleifera leaves and their functional chemical constituents. Food Chem. 2020;333:127478. doi: 10.1016/j.foodchem.2020.127478.", "ArticleIdList": ["10.1016/j.foodchem.2020.127478", "32663752"]}, {"Citation": "Kim D.S., Choi M.H., Shin H.J. Extracts of Moringa oleifera leaves from different cultivation regions show both antioxidant and antiobesity activities. J. Food Biochem. 2020;44:e13282. doi: 10.1111/jfbc.13282.", "ArticleIdList": ["10.1111/jfbc.13282", "32436270"]}, {"Citation": "Melilli M.G., Pagliaro A., Scandurra S., Gentile C., Di Stefano V. Omega-3 rich foods: Durum wheat spaghetti fortified with Portulaca oleracea. Food Biosci. 2020;37:100730. doi: 10.1016/j.fbio.2020.100730.", "ArticleIdList": ["10.1016/j.fbio.2020.100730", "PMC7353616", "32531917"]}, {"Citation": "Nemzer B., Al-Taher F., Abshiru N. Phytochemical composition and nutritional value of different plant parts in two cultivated and wild purslane (Portulaca oleracea L.) genotypes. Food Chem. 2020;320:126621. doi: 10.1016/j.foodchem.2020.126621.", "ArticleIdList": ["10.1016/j.foodchem.2020.126621", "32203838"]}, {"Citation": "Saratale G.D., Saratale R.G., Cho S.-K., Ghodake G., Bharagava R.N., Park Y., Mulla S.I., Kim D.-S., Kadam A., Nair S., et al. Investigation of photocatalytic degradation of reactive textile dyes by Portulaca oleracea-functionalized silver nanocomposites and exploration of their antibacterial and antidiabetic potentials. J. Alloy. Compd. 2020;833:155083. doi: 10.1016/j.jallcom.2020.155083.", "ArticleIdList": ["10.1016/j.jallcom.2020.155083"]}, {"Citation": "Hu Q., Niu Q., Song H., Wei S., Wang S., Yao L., Li Y.P. Polysaccharides from Portulaca oleracea L. regulated insulin secretion in INS-1 cells through voltage-gated Na(+) channel. Biomed. Pharm. 2019;109:876\u2013885. doi: 10.1016/j.biopha.2018.10.113.", "ArticleIdList": ["10.1016/j.biopha.2018.10.113", "30551541"]}, {"Citation": "Zheng G., Mo F., Ling C., Peng H., Gu W., Li M., Chen Z. Portulaca oleracea L. alleviates liver injury in streptozotocin-induced diabetic mice. Drug Des. Devel. 2018;12:47\u201355. doi: 10.2147/DDDT.S121084.", "ArticleIdList": ["10.2147/DDDT.S121084", "PMC5749558", "29343942"]}, {"Citation": "Lee J.H., Park J.E., Han J.S. Portulaca oleracea L. extract reduces hyperglycemia via PI3k/Akt and AMPK pathways in the skeletal muscles of C57BL/Ksj-db/db mice. J. Ethnopharmacol. 2020;260:112973. doi: 10.1016/j.jep.2020.112973.", "ArticleIdList": ["10.1016/j.jep.2020.112973", "32416244"]}, {"Citation": "Chen D., Yao J.-N., Liu T., Zhang H.-Y., Li R.-R., Zhang Z.-J., Gu X.-Z. Research and application of Portulaca oleracea in pharmaceutical area. Chin. Herb. Med. 2019;11:150\u2013159. doi: 10.1016/j.chmed.2019.04.002.", "ArticleIdList": ["10.1016/j.chmed.2019.04.002"]}, {"Citation": "Park J.E., Park J.Y., Seo Y., Han J.S. A new chromanone isolated from Portulaca oleracea L. increases glucose uptake by stimulating GLUT4 translocation to the plasma membrane in 3T3-L1 adipocytes. Int. J. Biol. Macromol. 2019;123:26\u201334. doi: 10.1016/j.ijbiomac.2018.10.206.", "ArticleIdList": ["10.1016/j.ijbiomac.2018.10.206", "30389528"]}, {"Citation": "Guerrero-Solano J.A., Jaramillo-Morales O.A., Jimenez-Cabrera T., Urrutia-Hernandez T.A., Chehue-Romero A., Olvera-Hernandez E.G., Bautista M. Punica protopunica Balf. the Forgotten Sister of the Common Pomegranate (Punica granatum L.): Features and Medicinal Properties-A Review. Plants. 2020;9:1214. doi: 10.3390/plants9091214.", "ArticleIdList": ["10.3390/plants9091214", "PMC7570187", "32947914"]}, {"Citation": "Chaves F.M., Pavan I.C.B., da Silva L.G.S., de Freitas L.B., Rostagno M.A., Antunes A.E.C., Bezerra R.M.N., Simabuco F.M. Pomegranate juice and peel extracts are able to inhibit proliferation, migration and colony formation of prostate cancer cell lines and modulate the Akt/mTOR/S6K signaling pathway. Plant. Foods Hum. Nutr. 2020;75:54\u201362. doi: 10.1007/s11130-019-00776-0.", "ArticleIdList": ["10.1007/s11130-019-00776-0", "31838616"]}, {"Citation": "Melgarejo-S\u00e1nchez P., N\u00fa\u00f1ez-G\u00f3mez D., Mart\u00ednez-Nicol\u00e1s J.J., Hern\u00e1ndez F., Legua P., Melgarejo P. Pomegranate variety and pomegranate plant part, relevance from bioactive point of view: A review. Bioresour. Bioprocess. 2021;8:1\u201329. doi: 10.1186/s40643-020-00351-5.", "ArticleIdList": ["10.1186/s40643-020-00351-5"]}, {"Citation": "Jandari S., Hatami E., Ziaei R., Ghavami A., Yamchi A.M. The effect of pomegranate (Punica granatum) supplementation on metabolic status in patients with type 2 diabetes: A systematic review and meta-analysis. Complement. Med. 2020;52:102478. doi: 10.1016/j.ctim.2020.102478.", "ArticleIdList": ["10.1016/j.ctim.2020.102478", "32951728"]}, {"Citation": "Estrada-Luna D., Martinez-Hinojosa E., Cancino-Diaz J.C., Belefant-Miller H., Lopez-Rodriguez G., Betanzos-Cabrera G. Daily supplementation with fresh pomegranate juice increases paraoxonase 1 expression and activity in mice fed a high-fat diet. Eur. J. Nutr. 2018;57:383\u2013389. doi: 10.1007/s00394-017-1394-2.", "ArticleIdList": ["10.1007/s00394-017-1394-2", "28243786"]}, {"Citation": "Li T., Zhang L., Jin C., Xiong Y., Cheng Y.Y., Chen K. Pomegranate flower extract bidirectionally regulates the proliferation, differentiation and apoptosis of 3T3-L1 cells through regulation of PPARgamma expression mediated by PI3K-AKT signaling pathway. Biomed. Pharm. 2020;131:110769. doi: 10.1016/j.biopha.2020.110769.", "ArticleIdList": ["10.1016/j.biopha.2020.110769", "33152931"]}, {"Citation": "Banihani S.A., Fashtaky R.A., Makahleh S.M., El-Akawi Z.J., Khabour O.F., Saadeh N.A. Effect of fresh pomegranate juice on the level of melatonin, insulin, and fasting serum glucose in healthy individuals and people with impaired fasting glucose. Food Sci. Nutr. 2020;8:567\u2013574. doi: 10.1002/fsn3.1344.", "ArticleIdList": ["10.1002/fsn3.1344", "PMC6977483", "31993180"]}, {"Citation": "Les F., Arbones-Mainar J.M., Valero M.S., Lopez V. Pomegranate polyphenols and urolithin A inhibit alpha-glucosidase, dipeptidyl peptidase-4, lipase, triglyceride accumulation and adipogenesis related genes in 3T3-L1 adipocyte-like cells. J. Ethnopharmacol. 2018;220:67\u201374. doi: 10.1016/j.jep.2018.03.029.", "ArticleIdList": ["10.1016/j.jep.2018.03.029", "29604377"]}, {"Citation": "Cano-Lamadrid M., Tkacz K., Turkiewicz I.P., Nowicka P., Hernandez F., Lech K., Carbonell-Barrachina A.A., Wojdylo A. Inhibition of enzymes associated with metabolic and neurological disorder by dried pomegranate sheets as a function of pomegranate cultivar and fruit puree. J. Sci. Food Agric. 2020;101:2294\u20132303. doi: 10.1002/jsfa.10850.", "ArticleIdList": ["10.1002/jsfa.10850", "33006384"]}, {"Citation": "Chakraborty M., Ahmed M.G., Bhattacharjee A. Potential pharmacodynamic and pharmacokinetic interaction of pomegranate juice and nateglinide against diabetis induced complications in rats. Synergy. 2017;5:1\u20136. doi: 10.1016/j.synres.2017.11.002.", "ArticleIdList": ["10.1016/j.synres.2017.11.002", "PMC5741395", "29296562"]}, {"Citation": "Khajebishak Y., Payahoo L., Alivand M., Alipour B. Punicic acid: A potential compound of pomegranate seed oil in Type 2 diabetes mellitus management. J. Cell. Physiol. 2019;234:2112\u20132120. doi: 10.1002/jcp.27556.", "ArticleIdList": ["10.1002/jcp.27556", "30317607"]}, {"Citation": "Ahmad M.F., Ahmad F.A., Ashraf S.A., Saad H.H., Wahab S., Khan M.I., Ali M., Mohan S., Hakeem K.R., Athar M.T. An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. J. Herb. Med. 2021;25:100404. doi: 10.1016/j.hermed.2020.100404.", "ArticleIdList": ["10.1016/j.hermed.2020.100404", "PMC7501064", "32983848"]}, {"Citation": "Hossain M.S., Sharfaraz A., Dutta A., Ahsan A., Masud M.A., Ahmed I.A., Goh B.H., Urbi Z., Sarker M.M.R., Ming L.C. A review of ethnobotany, phytochemistry, antimicrobial pharmacology and toxicology of Nigella sativa L. Biomed. Pharm. 2021;143:112182. doi: 10.1016/j.biopha.2021.112182.", "ArticleIdList": ["10.1016/j.biopha.2021.112182", "34649338"]}, {"Citation": "Malhotra B., Kulkarni G.T., Dhiman N., Joshi D.D., Chander S., Kharkwal A., Sharma A.K., Kharkwal H. Recent advances on Berberis aristata emphasizing berberine alkaloid including phytochemistry, pharmacology and drug delivery system. J. Herb. Med. 2021;27:100433. doi: 10.1016/j.hermed.2021.100433.", "ArticleIdList": ["10.1016/j.hermed.2021.100433"]}, {"Citation": "Zhang Y., Ma J., Zhang W. Berberine for bone regeneration: Therapeutic potential and molecular mechanisms. J. Ethnopharmacol. 2021;277:114249. doi: 10.1016/j.jep.2021.114249.", "ArticleIdList": ["10.1016/j.jep.2021.114249", "34058315"]}, {"Citation": "Abdel-Hafez S.M., Hathout R.M., Sammour O.A. Attempts to enhance the anti-cancer activity of curcumin as a magical oncological agent using transdermal delivery. Adv. Tradit. Med. 2020;21:15\u201329. doi: 10.1007/s13596-020-00439-5.", "ArticleIdList": ["10.1007/s13596-020-00439-5"]}, {"Citation": "Quispe C., Cruz-Martins N., Manca M.L., Manconi M., Sytar O., Hudz N., Shanaida M., Kumar M., Taheri Y., Martorell M., et al. Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases. Oxid. Med. Cell Longev. 2021;2021:3149223. doi: 10.1155/2021/3149223.", "ArticleIdList": ["10.1155/2021/3149223", "PMC8470924", "34584616"]}, {"Citation": "Fernandes A., Bancessi A., Pinela J., Dias M.I., Liberal A., Calhelha R.C., Ciric A., Sokovic M., Catarino L., Ferreira I., et al. Nutritional and phytochemical profiles and biological activities of Moringa oleifera Lam. edible parts from Guinea-Bissau (West Africa) Food Chem. 2021;341:128229. doi: 10.1016/j.foodchem.2020.128229.", "ArticleIdList": ["10.1016/j.foodchem.2020.128229", "33038772"]}, {"Citation": "Mohanty M., Mohanty S., Bhuyan S.K., Bhuyan R. Phytoperspective of Moringa oleifera for oral health care: An innovative ethnomedicinal approach. Phytother. Res. 2021;35:1345\u20131357. doi: 10.1002/ptr.6896.", "ArticleIdList": ["10.1002/ptr.6896", "33089602"]}, {"Citation": "Duan Y., Ying Z., He F., Ying X., Jia L., Yang G. A new skeleton flavonoid and a new lignan from Portulaca oleracea L. and their activities. Fitoterapia. 2021;153:104993. doi: 10.1016/j.fitote.2021.104993.", "ArticleIdList": ["10.1016/j.fitote.2021.104993", "34284073"]}, {"Citation": "Khazdair M.R., Gholamnezhad Z., Rezaee R., Boskabady M.H. Immuno-modulatory and anti-inflammatory effects of Thymus vulgaris, Zataria multiflora, and Portulaca oleracea and their constituents. Pharmacol. Res. Mod. Chin. Med. 2021;1:100010. doi: 10.1016/j.prmcm.2021.100010.", "ArticleIdList": ["10.1016/j.prmcm.2021.100010"]}, {"Citation": "Abdulmalek S., Eldala A., Awad D., Balbaa M. Ameliorative effect of curcumin and zinc oxide nanoparticles on multiple mechanisms in obese rats with induced type 2 diabetes. Sci. Rep. 2021;11:20677. doi: 10.1038/s41598-021-00108-w.", "ArticleIdList": ["10.1038/s41598-021-00108-w", "PMC8526574", "34667196"]}, {"Citation": "Ezzat S.M., El Bishbishy M.H., Aborehab N.M., Salama M.M., Hasheesh A., Motaal A.A., Rashad H., Metwally F.M. Upregulation of MC4R and PPAR-alpha expression mediates the anti-obesity activity of Moringa oleifera Lam. in high-fat diet-induced obesity in rats. J. Ethnopharmacol. 2020;251:112541. doi: 10.1016/j.jep.2020.112541.", "ArticleIdList": ["10.1016/j.jep.2020.112541", "31911179"]}, {"Citation": "Ramadan B.K., Schaalan M.F., Tolba A.M. Hypoglycemic and pancreatic protective effects of Portulaca oleracea extract in alloxan induced diabetic rats. BMC Complement. Altern Med. 2017;17:37. doi: 10.1186/s12906-016-1530-1.", "ArticleIdList": ["10.1186/s12906-016-1530-1", "PMC5225634", "28077129"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "10", "Day": "23"}, {"Year": "2021", "Month": "11", "Day": "9"}, {"Year": "2021", "Month": "11", "Day": "10"}, {"Year": "2021", "Month": "11", "Day": "27", "Hour": "1", "Minute": "23"}, {"Year": "2021", "Month": "11", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["34833928", "PMC8618521", "10.3390/molecules26226836", "molecules26226836"]}}], "PubmedBookArticle": []}